References
- Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–9
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
- Roberts JM, Pearson G, Cutler J, Lindheimer M. NHLBI Working Group Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension 2003;41:437–45
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
- Hu D, Tian T. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clin Chim Acta 2011;413:533–6
- Okamoto A, Endo H. IGFBP1 and follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006;27:317–21
- Pryor-Koishi K, Nishizawa H, Kato T, et al. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. BJOG 2007;114:1128–37
- Guo J, Tian T, Lu D, Xia G. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. J Obstet Gynaecol Res 2012;7:988–96
- D'Antona D, Reis FM, Benedetto C, et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000;165:157–62
- Keelan JA, Taylor R, Schellenberg JC, et al. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99:267–74
- ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159–67
- Founds SA, Conley YP, Lyons-Weiler JF, et al. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009;1:15–24
- Biron-Shental T, Schaiff WT, Rimon E, et al. Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts. Placenta 2008;29:51–7
- Rizos D, Eleftheriades M, Karampas G, et al. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Eur J Obstet Gynecol Reprod Biol 2013;171:225–30
- Lai J, Syngelaki A, Poon LC, et al. Maternal serum soluble endoglin at 30–33 weeks in the prediction of preeclampsia. Fetal Diagn Ther 2013;33:149–55